Airway Epithelium Gene Expression: AEGIS IDE

Completed

Conditions studied: Lung Cancer

In brief

The purpose of the research study is to develop a new, more sensitive, and less invasive test for diagnosing lung cancer at an earlier stage, when it can more easily be cured. The investigators hypothesize that certain genes are expressed differently in current and former smokers who have lung cancer, and this difference in gene expression may be a biomarker for lung cancer.

Key facts

Study ID
NCT00746759
Run by
Allegro Diagnostics, Corp.
People needed
1331
Starts
2010-02-01
Expected to finish
2015-02-01
Last updated by the study team
2015-06-04

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.